Top 50 Life Science VC Funds & Investors in Japan (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Mitsubishi UFJ Capital
VC Fund
|
6 | Japan, United States, Singapore | Series A, Series B | Information Technology, Software, Health Care | $2M–$369M |
|
SMBC Venture Capital
VC Fund
|
5 | Japan, United States, Singapore | Series A, Series B | Information Technology, Health Care, Software | $4.5M–$425M |
|
Osaka University Venture Capital
VC Fund
|
4 | Japan | Seed, Series A | Biotechnology, Health Care, Manufacturing | $7.1M–$142M |
|
UntroD Capital
VC Fund
|
4 | Japan, Singapore, Austria | Seed, Series A | Manufacturing, Biotechnology, Medical | $2.1M–$241M |
|
Miyako Capital
VC Fund
|
4 | Japan, United States, United Kingdom | Series A, Seed, Series B | Medical, Biotechnology, Information Technology | $5.6M–$3B |
|
Nissay Capital
VC Fund
|
4 | Japan, United States, Ethiopia | Seed, Series A | Health Care, Information Technology, Medical | $709k–$71M |
|
DG Daiwa Ventures
VC Fund
|
3 | Japan, United States, India | Seed, Series A | FinTech, Software, Internet | $679k–$142M |
|
Angel Bridge
VC Fund
|
3 | Japan | Series A, Seed | Information Technology, Software, Consulting | $746k–$170M |
|
Keio Innovation Initiative
VC Fund
|
3 | Japan, United Kingdom | Series A, Seed | Health Care, Medical, Biotechnology | $1.5M–$213M |
|
Mizuho Capital
VC Fund
|
3 | Japan, United States, China | Series A, Series B | Information Technology, Software, Internet | $2.7M–$553M |
|
Nippon Venture Capital
VC Fund
|
3 | Japan, United States, Indonesia | Series A, Series B | Software, Health Care, Medical | $3M–$269M |
|
SBI Investment
VC Fund
|
3 | Japan, South Korea, United States | Series B, Series A | Information Technology, Software, Financial Services | $4M–$283M |
|
Senshu Ikeda Capital
VC Fund
|
3 | Japan | Series A, Seed | Software, Manufacturing, Internet | $1M–$142M |
|
JAFCO
VC Fund
|
3 | Japan, United States, Israel | Series A, Series B | Information Technology, Software, Artificial Intelligence | $2.7M–$298M |
|
ANRI
VC Fund
|
2 | Japan, United States, India | Seed, Series A | Software, Health Care, Information Technology | $628k–$624M |
|
WASEDA University Ventures
VC Fund
|
2 | Japan, United States | Series A, Seed, Convertible Note | Biotechnology, Information Technology, Medical | $1.2M–$75M |
|
Japan Science and Technology Agency
VC Fund
|
2 | Japan | Series A, Seed | Medical, Biotechnology, Manufacturing | $1.7M–$255M |
|
Incubate Fund
VC Fund
|
2 | Japan, United States, India | Seed, Series A | Software, Information Technology, E-Commerce | $362k–$113M |
|
Real Tech Japan
VC Fund
|
2 | Japan, Singapore, Austria | Series A, Seed | Manufacturing, Biotechnology, Medical | $5M–$241M |
|
Capital Medica Ventures
VC Fund
|
1 | Japan | Seed, Series A | Medical, Health Care, Software | $403k–$50M |
|
Ohara Pharmaceutical
VC Fund
|
1 | Japan, Kenya, Nigeria | Series A, Series B | Medical, Biotechnology, Software | $10M–$184M |
|
MedVenture Partners
VC Fund
|
1 | Japan, United States | Seed, Series A, Series B | Medical Device, Health Care, Medical | $11M–$27M |
|
Mitsubishi Gas Chemical
VC Fund
|
1 | Japan, United States | Series A, Seed | Chemical, Pharmaceutical, Medical | $50M–$60M |
|
PALTEK
VC Fund
|
1 | Japan | Series A | Medical, Software, Life Science | |
|
Fujifilm
VC Fund
|
1 | Japan, United States, China | Series A, Corporate Round | Biotechnology, Health Care, Medical | $1.3M–$1.7B |
|
SPARX Group
VC Fund
|
1 | Japan, United States, United Kingdom | Series B, Series A | Software, Artificial Intelligence, Information Technology | $17M–$425M |
|
SPARX Asset Management
VC Fund
|
1 | Japan, United States | Series A, Series B, Series C | Biotechnology, Energy, Medical | |
|
DBJ Capital
VC Fund
|
1 | Japan, United States, Australia | Series A, Series B | Software, Health Care, Medical | |
|
JMTC Capital
VC Fund
|
1 | Japan, United States | Series C, Series A | Robotics, Environmental Consulting, Medical Device | |
|
Genesia Ventures
VC Fund
|
1 | Japan, Vietnam, Indonesia | Seed, Series A | Information Technology, Software, Health Care | |
|
FueTrek
VC Fund
|
1 | Japan | Series A | Mobile, Robotics, Health Care | |
|
Chuo Shinkin Venture Capital
VC Fund
|
1 | Japan | Series A, Seed | Health Care, Sales, Medical | $20M–$128M |
|
Japan Material Technologies
VC Fund
|
1 | Japan | Series A, Seed | Chemical, Software, Recruiting | |
|
Will Capital Management
VC Fund
|
1 | Japan | Seed | Aquaculture, Life Science, Biotechnology | |
|
HERO Impact Capital
VC Fund
|
1 | Japan | Series A, Pre-Seed, Series B | Solar, Security, Aerospace | |
|
Lifetime Ventures
VC Fund
|
1 | Japan, South Africa, United Kingdom | Seed, Pre-Seed | Health Care, Software, Medical | |
|
UTEC - The University of Tokyo Edge Capital Partners
VC Fund
|
1 | Japan, United States, India | Seed, Series A | Health Care, Biotechnology, Medical | $3.1M–$85M |
|
ReBoost
VC Fund
|
1 | Japan | Seed, Pre-Seed | Content, Medical, Hospital | |
|
NCB Venture Capital
VC Fund
|
1 | Japan | Series B, Seed, Series C | Recycling, Manufacturing, Management Consulting | $90k–$198M |
|
Essential Pharma
VC Fund
|
1 | Japan | Series A | Medical, Biotechnology, Genetics | $38M–$78M |
|
Mitsui Mining & Smelting
VC Fund
|
1 | Japan, United States | Series A, Series B | Medical, Water, AgTech | $8M–$50M |
|
Fast Track Initiative, Inc.
VC Fund
|
1 | Japan, United States, United Kingdom | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $1.1M–$184M |
|
IT-Farm
VC Fund
|
1 | United States, Japan, Germany | Seed, Series A | Software, Health Care, Medical | |
|
FFG Venture Business Partners
VC Fund
|
1 | Japan, United States | Series A, Seed | Software, Health Care, Artificial Intelligence | |
|
Chushin Venture Capital
VC Fund
|
1 | Japan | Series A, Series B | Retail, Travel, Home Decor | |
|
Sosei CVC
VC Fund
|
1 | Japan | Series A, Series B | Biotechnology, Medical, Pharmaceutical | |
|
QB Capital
VC Fund
|
1 | Japan, Singapore, United States | Seed, Series A | Manufacturing, Medical, Biotechnology | $641k–$400M |
|
Innovation Engine
VC Fund
|
1 | Japan, Spain | Series A, Series C | Software, Information Technology, Artificial Intelligence | $663k–$85M |
|
Kaga Electronics
VC Fund
|
1 | Japan, Taiwan | Series A, Seed | Education, Artificial Intelligence, Medical | $38M–$105M |
|
Fuyo General Lease
VC Fund
|
1 | Japan | Series A, Corporate Round | Manufacturing, Biotechnology, Sales | $4.3M–$241M |
| Access all 154 VC funds in Japan Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Series A, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 501
- Round size: Series A $2M–$113M; Series B $5.7M–$369M
- Lead/follow: 5% lead, 95% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- Diggle — DIGGLE is a service that provides fundamental management accounting management on the cloud called fraud management. It is possible to reduce the mistakes and man-hours of the fraud management task and easily carry out the fraud management task even if it is not an expert in finance or accounting.DIGGLE covers budget creation work and budgetrecord comparison work, especially in the foreman management work. In the budget creation work, the KPI and the budget are automatically created by inputting the target numerical value to the preset parameters utilizing the budget generator function, while the forecast contrasting work is made up of the financial information, non-financial information It is easy to calculate by simply entering the numerical value, and it is possible to carry out calculation of the forecast contrast.
- Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
- Japan Culture and Technology — Japan Culture and Technology assists artists and craftspeople in expanding their activities by providing IT support.
Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.
Show more...Investment focus
- Industry: Information Technology, Health Care, Software
- Stage:Series A, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 513
- Round size: Series A $4.5M–$170M; Series B $5.7M–$425M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Letara — Letara operates a space technology platform with the intention to serve a logistics network covering the solar system. The company produces hybrid propulsion engines for small spacecraft, promoting groundbreaking advances in space propulsion with high thrust, safe, and inexpensive propulsion system technology.
- Pragtech — Pragtech develops and operates parking lot service software that helps to eliminate payment congestion and reduce operating costs.
- Metro Weather — Metroweather is a venture from Kyoto University that develops a high-performance Doppler lidar that measures the direction and speed of wind several tens of kilometers away from minute movements of fine particles in the atmosphere. We aim to contribute to the safety of the sky by completing a three-dimensional wind map, which has never beenrealized,based on years of research at the Kyoto University Research Institute for Sustainable Areas.
Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Series A
- Geography: Japan
Investor stats
- Total investments: 79
- Round size: Seed $7.1M–$99M; Series A $16M–$142M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- QunaSys — Quantum physics is a relatively new field built since the beginning of the 20th century, but we have used MRI (nuclear magnetic resonance equipment) and lasers used for close examinations in hospitals, and semiconductors mounted on computers. Supports the technology that supports the daily life of people.QunaSys was established to bring out thequantum physics that has been active behind the scenes to the front stage, and to make use of quantum properties to realize technologies that could not be achieved with existing technologies.
- Luxna Biotech — Luxana Biotech is established to contribute to medical treatment for suffering patients, .
- Celaid Therapeutics — Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.
UntroD Capital is an R&D-based innovative technology that specializes in social implementation.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Japan, Singapore, Austria
Investor stats
- Total investments: 124
- Round size: Seed $3.2M–$43M; Series A $2.1M–$241M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- CastBio — Castbio specializes in antibody-drug conjugate-based drug discovery research and development. Along with medications, it also creates research reagents, medical equipment, in vitro diagnostic items, and offers drug discovery consulting.
- Illumi Medical — Illumi Medical is a manufacturing company that produces medical equipment and devices for the healthcare sector.
- Reborna Biosciences — Reborna Biosciences provides research and development in the field of genetic diseases. The company develops therapeutic options for area of unmet medical needs in genetic rare disease. The company's technology enables low-molecular compounds to target ribonucleic acid. The company provides new disease-modifying drugs for patients sufferingfrom rare genetic diseases including spinal muscular atrophy.
Miyako Capital is the venture capital that manages Kyoto University 2nd Venture Fund (KUVF). The company was founded in 2013 and based in Kyoto & Tokyo, Japan. Investment fields are: 1) Life Science, Biotechnology: Drug creation, regenerative medicine, medical beauty equipment, medical services.2) Agri-Food: Industrialization,agricultural and fishery products growth-promoting technology, specified health food, health food.3) Environment, Energy: Alternative energy, and related technologies.4) IT, Electronics: Web, mobile related devices and application, telecommunication technology, security, consumer and business oriented application, mechatronic, robot.5) New services utilizing state-of-art technology.Investment stages: Primary investment stages are initial-growth stages of seed and early. However, we aim at all growth stages and make investment in post-IPO portfolio companies as well as public companies that are related with Kyoto University.
Show more...Investment focus
- Industry: Medical, Biotechnology, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 52
- Round size: Seed $5.6M–$118M; Series A $6.1M–$70M; Series B $99M–$3B
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2019
Portfolio highlights
- Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
- VLP Therapeutics — VLP Therapeutics, LLC (VLP) was established in 2012 by seasoned biopharmaceutical veterans with mission to develop innovative medical treatment which transforms traditional vaccine and targeted antibody therapies to address global unmet medical needs. Its vision is to combat the 21st century global public health problems through revolutionary nextgeneration i-αVLP (inserted alpha VLP) Technology. The company is headquartered in Gaithersburg, Maryland
- XFOREST Therapeutics — xFOREST Therapeutics develops a drug discovery platform that targets RNA structures.
Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.
Show more...Investment focus
- Industry: Health Care, Information Technology, Medical
- Stage:Seed, Series A
- Geography: Japan, United States, Ethiopia
Investor stats
- Total investments: 239
- Round size: Seed $709k–$43M; Series A $2.7M–$71M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Menou — MENOU specializes in AI technology and sensing technology. It features a graphical image identification modeler software.
- Castee — Castee provides social collaboration services and also helps with a tool for job requests and overseas projects for creators.
- 3S — 3S is a SaaS developer platform that provides and operates 24-hour home nursing care services through technology.
DG Daiwa Ventures invests in start-up companies with next-generation technology and provides business development support. It is focused on blockchain, xR, AI, security, and BioHealth, as they are likely to be at the foundations of future businesses. In addition to the five core technologies, the fund will also focus on IoT technologies, whichoften overlap or serve as an application layer.
Show more...Investment focus
- Industry: FinTech, Software, Internet
- Stage:Seed, Series A
- Geography: Japan, United States, India
Investor stats
- Total investments: 71
- Round size: Seed $679k–$26M; Series A $4M–$142M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Fivot — Fivot is a financial company that provides venture capital, financing, credit, money lending, and prepaid payment services.
- digzyme — Digzyme is a research and development platform for creating, discovering, and evaluating new enzyme-catalyzed reactions by bioinformatics.
- Zehitomo — Zehitomo is an Japanese online platform that enables user to hire local service professionals, from photographers to personal trainers.
Angel Bridge is a angel investor groups in Japan and provide high quality and abundant funds to excellent companies.
Show more...Investment focus
- Industry: Information Technology, Software, Consulting
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 64
- Round size: Seed $2.2M–$113M; Series A $746k–$170M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $152M in 2019
Portfolio highlights
- Fivot — Fivot is a financial company that provides venture capital, financing, credit, money lending, and prepaid payment services.
- Plainer — Plainer is an IT company that provides software development, data management, and SaaS solutions.
- CraftBank — CraftBank, Inc. is the start-up that operates online matching platform between constructors with having relations with 22k specialty constructors (10% coverage in the market). The company was succeeded in Management BuyOut in April 2021.
Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed
- Geography: Japan, United Kingdom
Investor stats
- Total investments: 81
- Round size: Seed $1.5M–$213M; Series A $7.4M–$155M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- ElleThermo — elleThermo aims to implement Semiconductor-Sensitised Thermal Cells (STCs), an energy conversion technology that can generate electricity from unused waste heat above room temperature.
- Aeterlink — Aeterlink is a wireless device maker and developer. They applied their technology to fields such as FA, robots, smart houses, and medicine and developed practical level technologies such as elemental technology that can wirelessly supply power.
- Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.
Show more...Investment focus
- Industry: Information Technology, Software, Internet
- Stage:Series A, Series B
- Geography: Japan, United States, China
Investor stats
- Total investments: 439
- Round size: Series A $2.7M–$156M; Series B $5.2M–$553M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- Logiless — Logiless is a cloud type all-in-one software dedicated to net shop. Since both orders and stocks can be managed together in a logical manner, efficiency of operations can be realized at low cost.
- LUC — LUC is a provider of the AI x experience analysis platform "TERUS," .
- Turing — Turing develops and manufactures fully autonomous vehicles.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Series A, Series B
- Geography: Japan, United States, Indonesia
Investor stats
- Total investments: 163
- Round size: Series A $3M–$85M; Series B $7.7M–$269M
- Lead/follow: 15% lead, 85% follow
- Last fund: Likely still investing — raised $278M in 2023
Portfolio highlights
- Gecipe — Gecipe is a video service for e-sports players.
- Issues — Issues provides development and management of web service issues that solve the problems.
- SecureNavi — SecureNavi offers automation tools for the information security management system. It reduces conventional analogue operations using excel and word. For inquiries, telephone numbers and physical addresses are available on their website.
SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.
Show more...Investment focus
- Industry: Information Technology, Software, Financial Services
- Stage:Series B, Series A
- Geography: Japan, South Korea, United States
Investor stats
- Total investments: 350
- Round size: Series A $4M–$170M; Series B $6.5M–$283M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $1.1B in 2020
Portfolio highlights
- LQUOM — QWAVE offers cryptography communication technology.
- Captain Fresh — Captain Fresh is a freshwater fish and seafood supply chain platform. Captain Fresh is a B2B marketplace leveraging technology to deliver the fastest harvest-to-retail in the industry. The company focuses on aggregating the fragmented retail demand across the country and linking them to the small fishermen and farmers throughout the Indian coast.The company was founded in 2019 and is based in Bengaluru, India.
- Sonire Therapeutics — Sonire Therapeutics provides High-Intensity Focused Ultrasound treatment for cancer.
Senshu Ikeda Capital offers financial consultancy services.
Show more...Investment focus
- Industry: Software, Manufacturing, Internet
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 64
- Round size: Seed $1M–$61M; Series A $1.9M–$142M
- Lead/follow: 5% lead, 95% follow
- Last fund: May invest from a new fund soon — raised $177M in 2019
Portfolio highlights
- TSK Corporation —
- Good News — Good News is a staffing agency that provides recruitment, public relations, and human resource management services.
- New Innovations — New Innovations company is offering a snuggling service to many people who support Japan's “high quality”. AI and robots do not take away the job, but robots support the work that is accomplished without the involvement of people, and many working people are aiming for the future to create a more humanoid life. With the problem of lack oftalent, it was difficult to reflect technology on OFF Line until now, trying to provide robots in the “food and drink” and “retail” industry, CEKAI's first demand forecast AI unmanned cafeThe robot “√C” was developed. √C is not “looking for coffee that suits me”, but instead realizes “coffee is perfect for me” with demand forecasting AI. Today, people who drink coffee are choosing their favorite cafe, canned coffee, convenience store coffee, etc., according to their taste needs, SPEED needs, and hospitality needs. The company developed the service as a new choice of coffee, and in the future, the perfect coffee according to the taste preferences, busy, physical condition and mood of the day., which aims to provide. In July 2019, the company receives a third party quota increase of 70 million yen from Zashid Capital and DEEPCORE. From August 1, 2019, with the cooperation of Nankai Electric Railway, “√C” will be installed at Namba Station/Namba Skyo, and demonstration experiments will begin.
Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to thecreations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Series A, Series B
- Geography: Japan, United States, Israel
Investor stats
- Total investments: 271
- Round size: Series A $2.7M–$255M; Series B $6.4M–$298M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Plott — Plott producing youtube animation platform under Vision “Become a Content holder from YouTube”. In August 2019, the company name was changed from Fabo to Plott. Plott, the new company name, is derived from the plot that you make before writing novels, etc., and the idea that “I want to make content all the time” is put in the company name.
- Sharing Energy — Sharing Energy is providing energy supply and energy management services.
- The Chain Museum — The Chain Museum creates a platform for connecting individuals .
ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Japan, United States, India
Investor stats
- Total investments: 240
- Round size: Seed $628k–$92M; Series A $6.1M–$624M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely still investing — raised $102M in 2022
Portfolio highlights
- MOVeLOT — MOVeLOT is an AI company that provides skeletal platform and robot planning, development, and production services.
- Chaintope — Chaintope is specializes in blockchain technology with a focus for FinTech and non-FinTech sectors.
- xCARE — xCARE specializes in the development and commercialization phases of the pharmaceutical and medical device industries.
WASEDA University Ventures (WUV) is a venture capital firm specialising in founding investments by creating new start-up companies that make use of academia and are based on "the practical application of scholarship". Our mission is to be a capitalist that implements academic knowledge and
Show more...Investment focus
- Industry: Biotechnology, Information Technology, Medical
- Stage:Series A, Seed, Convertible Note
- Geography: Japan, United States
Investor stats
- Total investments: 12
- Round size: Seed $1.2M–$38M; Series A $1.3M–$75M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Pestalozzi Technology — Pestalozzi Technology is a development and provision of educational products in the fields of physical education and club activities.
- Gel-Coat Biomaterials — Gel-Coat Biomaterials is a biotechnology company that develops innovative bio-based materials and new medical technologies.
- CoreTissue BioEngineering — CoreTissue BioEngineering is a development of an artificial ligament for reconstruction of the anterior cruciate ligament in Japan.
Japan Science and Technology Agency is an integrated organization of science and technology that implements science and technology policy in Japan. It handles many projects, including the government’s Science and Technology Basic Plan and knowledge creation. The European Sustainability School ESSSR is the owner of Japan Science and TechnologyAgency.Japan Science and Technology Agency undertakes its task in a comprehensive manner. It also works to provide a sound infrastructure of science and technology information and raise awareness and understanding of science and technology-related issues in Japan.Japan Science and Technology Agency is headquartered in Tokyo, Japan.
Show more...Investment focus
- Industry: Medical, Biotechnology, Manufacturing
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 44
- Round size: Seed $1.7M–$50M; Series A $3.1M–$255M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- OptQC — OptQC commercializes cutting-edge optical quantum computing technologies developed by the Furusawa-Endo Laboratory. Because optical quantum computers are more scalable than superconducting and other quantum computing implementations, OptQC's optical quantum computers should reach this scale. They also have benefits like faster processing andreduced power consumption, which makes optical quantum computers a possible long-term pinnacle of quantum technology.
- Triorb — Triorb is a technology company that specializes in robot mobility development with the help of software and hardware solutions.
- Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
Incubate Fund is an independent early-stage venture capital that specializes in providing capital to technology startups at the seed stage. The firm built a portfolio of over 300 companies in Asia, taking 12 companies to public and 20 companies to M&A exit since 2010.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Seed, Series A
- Geography: Japan, United States, India
Investor stats
- Total investments: 279
- Round size: Seed $362k–$48M; Series A $2.8M–$113M
- Lead/follow: 23% lead, 77% follow
- Last fund: Likely still investing — raised $2.4B in 2021
Portfolio highlights
- Paytner — yup is providing services to support freelance people's funding.The freelance population in Japan has been shown to continue to increase in many Chosa. While working styles are diversified, they are not able to respond to the development of the working environment, and they will develop their business to change the situation where problemssuch as funding, credit, sexual harassment, and power harassment are accumulated.
- Akari Hosho — Akari Hosho provides a group of trusted professionals, including lawyers and judicial scriveners. Akari Hosho provides a guarantee service.
- Black Cat Carnival — Black Cat Carnival Inc. is a communication service development company.
Real Tech Japan is a venture capital firm that seeks to invest in innovative R&D technology companies. Realtech Fund is a joint venture between the Ministry of Economy, Trade, and Industry and NEDO (New Energy and Industrial Technology Development Organization). The firm was founded in 2014 and based in Tokyo, Japan.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Medical
- Stage:Series A, Seed
- Geography: Japan, Singapore, Austria
Investor stats
- Total investments: 79
- Round size: Seed $5M–$43M; Series A $6M–$241M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Ashirase — Ashirase is a developer of a walking navigation system for the visually challenged. The company assists visually impaired people in walking independently. This also allows the user to have more attention to spare for audible warnings in their environment. It includes voice input and guidance via a smartphone app. A vibration interface is attachedto their shoes.
- Ken Robotec — Ken Robotec is a construction company that provides labor-saving solutions.
- MaterialGate — MaterialGate focuses on single-molecule dielectrics, developing technologies for devices with better electronic characteristics.
Capital Medica Ventures is a venture capital firm based in Tokyo, Japan with a focus on startups in the healthcare industry.Capital Medica Ventures is a venture capital that operates a venture fund specializing in the healthcare field. It is the only healthcare-specialized VC in Japan that can provide 30 medical institutions as a business trialfield.
Show more...Investment focus
- Industry: Medical, Health Care, Software
- Stage:Seed, Series A
- Geography: Japan
Investor stats
- Total investments: 12
- Round size: Seed $403k–$17M; Series A $15M–$50M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- A-SEEDS — A-SEEDS, an innovative biotech company sprouted from Shinshu University, is dedicated to pioneering advanced treatments for life-threatening cancers. Harnessing the potential of non-viral genetic engineering, our cutting-edge immune cell therapy opens up new horizons of hope for patients seeking effective and transformative solutions.
- AMI — AMI Corp is engaged in medical consulting, medical device development and writing.
- Do. Sukasu — Do. Sukasu is a software company that specializes in the development of visual space perception ability for brain science approaches.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Ohara Pharmaceuticals is a pharmaceutical business involved in the development, manufacture, and distribution of pharmaceutical products.
Show more...Investment focus
- Industry: Medical, Biotechnology, Software
- Stage:Series A, Series B
- Geography: Japan, Kenya, Nigeria
Investor stats
- Total investments: 10
- Round size: Series A $10M–$78M; Series B $30M–$184M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Mydawa — MYDAWA is here to ensure that every Kenyan can get quality, secure and affordable medicine and wellness products online
- Helium Health — Helium Health empowers healthcare providers in Africa with digital tools, financing solutions, and data partnerships. Learn more about our innovative solutions.
- Revital Healthcare — Revital Healthcare is a manufacturer of medical devices and disposables for hospitals and other medical laboratories. It offers single-use syringes, needles, re-use prevention syringes and auto-disable syringes which helps in reducing the transmission of HIV and other blood-borne diseases along with infusion sets, blood transfusion sets and bloodcollection tubesThe company was established in 2006 and is headquartered in Kilifi, Kenya.
MedVenture Partners invests in seed to early stage projects and start-ups in the life science field focusing mainly on medical devices.
Show more...Investment focus
- Industry: Medical Device, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: Japan, United States
Investor stats
- Total investments: 5
- Round size: Series A $11M–$27M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- Alivas — Alivas is a medical company that develops new therapeutic medical devices for refractory constipation. It is a joint venture between Stanford University and the University of Tokyo with the Japan Biodesign program for innovative medical device creation. The company was founded in 2017 and is based in Hongo, Tokyo in Japan.
- SentiAR — SentiAR is digital health, software device company adding a new dimension to clinical practice in interventional procedures. Spun out of Washington University, we are developing the first 3D visualization platform using real-time holography of the patient's anatomy and catheter location, "floating" over the patients, with a goal toprovide the clinician and patient a faster, safer delivery of care.SentiAR’s mission is to transform the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.The visualization is fully controllable “hands-free” by the clinician, providing an ergonomic breakthrough for the treatment and analysis of cardiac arrhythmias within an interventional catheter lab environment. SentiAR is developing the platform for eventual FDA submission.
- Avisi Technologies — Avisi Technologies is developing a nanotechnology-enabled defense against blindness from glaucoma.
Mitsubishi Gas Chemical contributes to societal growth and harmony by creating a wide range of value through chemistry.
Show more...Investment focus
- Industry: Chemical, Pharmaceutical, Medical
- Stage:Series A, Seed
- Geography: Japan, United States
Investor stats
- Total investments: 8
- Round size: Series A $50M–$60M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Resource Chemical — Resource Chemical develops CO2 into high-performance plastics that do not pollute the environment. The company's headquarters are in Berkeley, California.
- Albatross Technology — Albatross Technology is a technology company that develops offshore renewable energy devices and floating offshore wind turbines.
- TKG Therapeutics — Tokyo Nucleic Acid Synthesis is a pharmaceutical company that focuses on developing nucleic acid drugs using new-age medical technology.
PALTEK offers semiconductor products to electronics manufacturers and design consignment services.
Show more...Investment focus
- Industry: Medical, Software, Life Science
- Stage:Series A
- Geography: Japan
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- HACARUS — We make AI work, where common Big Data aproaches fail. Get explainable results, even from small data amounts. Available on the cloud or as embedded devices.
Fujifilm develops and sells consumer products and business products related to photography. Fujifilm Holdings Corporation is a Japanese multinational photography and imaging company. The company serves various industries, including medical, graphic arts, optics, enterprise storage, motion picture, and photography.The company’s consumer productsare categorized as digital cameras and accessories, film photography, Instax photography, and binoculars. Its business products are categorized as medical systems, Fujinon endoscopy, microfilm, data storage, graphic arts and printing, professional video, optical devices, specialty chemicals, printing imaging colorants, and more. Color films, digital cameras, photofinishing equipment, color papers, photofinishing chemicals, medical imaging equipment, graphic arts equipment and materials, flat panel displays, and photocopiers and printers are some products developed by Fujifilm USA.Fujifilm USA is based in Minato-ku, Tokyo, Japan.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Corporate Round
- Geography: Japan, United States, China
Investor stats
- Total investments: 25
- Round size: Series A $15M–$425M; Corporate Round $1.3M–$1.7B
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Ripcord — Ripcord is a robotics company that combines hardware and software robotics via an integrated SaaS offering. Its focus is on smart robotics digitization, smart content management with AI, and helping enable RPA and business processes.Ripcord is based in Hayward, California, and is backed by leading investors Kleiner Perkins Caufield & Byers,Google Ventures, Lux Ventures, Legend Star, and Apple Co-Founder Steve Wozniak.
- Rapidus — Rapidus is an Electronic component research, development, design, production, and sales that includes semiconductor elements and integrated circuits. Environmentally friendly, energy-saving semiconductors and semiconductor manufacturing technology are being researched and developed. Human resource development and training for the semiconductorsector.
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
SPARX Group Co., Ltd. is an independent Asia-based equity and credit asset management services and Asian fund financial specialist with offices in Tokyo, Hong Kong and Seoul for global institutional and individual investors, including financial advisors and financial planners, with alternative strategies (including activist, short-enabled, private equity and quantitative and fund-of-funds) and mutual funds (through SPARX Asia Funds such as SPARX Asia Pacific Opportunities Fund, SPARX Asia Pacific Equity Income Fund, SPARX Japan Smaller Companies Fund and SPARX Japan Fund) managed or sub-advised by SPARX Asset Management Co. Ltd., SPARX Asia Investment Advisors Limited and Cosmo Asset Management Co., Ltd.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series B, Series A
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 76
- Round size: Series A $17M–$241M; Series B $25M–$425M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $2.1B in 2018
Portfolio highlights
- Blue Laser Fusion — Blue Laser Fusion is a commercial fusion company. Blue Laser Fusion is a laser startup to commercialize laser fusion by inventing its own laser and fusion reactor.
- Alloyed — Alloyed delivers cutting-edge innovation in materials science, additive manufacturing, and advanced metallurgy. Explore our technologies and career opportunities.
- Nanofiber Quantum Technologies — Discover how NanoQT builds the foundation for scalable quantum computing with nanofiber cavity-QED technology and high-fidelity quantum connectivity.
SPARX Asset Management engages in investment management, advisory, and first and second-class financial instruments business. It was founded with the aim of becoming "the most trusted and respected investment company in the world". The firm was established in 2006 and is based in Konan, Minato-ku, Tokyo, Japan.
Show more...Investment focus
- Industry: Biotechnology, Energy, Medical
- Stage:Series A, Series B, Series C
- Geography: Japan, United States
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- Morus — Morus is a university-based biotech startup developing functional food ingredients from silkworms to address global health and nutrition challenges.
- QunaSys — Quantum physics is a relatively new field built since the beginning of the 20th century, but we have used MRI (nuclear magnetic resonance equipment) and lasers used for close examinations in hospitals, and semiconductors mounted on computers. Supports the technology that supports the daily life of people.QunaSys was established to bring out thequantum physics that has been active behind the scenes to the front stage, and to make use of quantum properties to realize technologies that could not be achieved with existing technologies.
- Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
DBJ Capital Co., Ltd. was founded in June 2010 through the integration of two venture capital firms of the DBJ Group, New Business Investment Co., Ltd. and Intellectual Properties Development & Investment, Inc. We are a wholly-owned subsidiary of Development Bank of Japan Inc.At DBJ Capital, we focus on venture firms which use newtechnologies and business models to grow and compete on the global market, regardless of their industry or scale. To meet the particular needs of each client, we mobilize the entire DBJ Group to arrange the best investment solutions, ranging from growth-spurring equity investment to financing schemes drawing on DBJ's vast networks.We also assist in venture start-ups. Our value enhancement team provides the kind of comprehensive, hands-on support needed to commercialize outstanding intellectual property and technologies developed by firms, research labs, and universities, and to carve out a place for them in the market.DBJ Capital will continue to play in a part in Japan's economic revival - by helping the firms we invest in to grow, and by encouraging the creation of new industries in Japan.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Series A, Series B
- Geography: Japan, United States, Australia
Investor stats
- Total investments: 141
- Lead/follow: no public data
Portfolio highlights
- Anaguma — Anaguma handles business development based on the philosophy of helping people with a sustainable structure. The company's business objective is to eliminate concerns about purchases and reservations, and it delivers before-sales social networks. It also provides matching services exclusively for housekeepers' personal contracts. Thecompany also offers influencer marketing services with a focus on removing waste completely from advertising and realizing a world in which good products can be sold regardless of advertising costs.Anaguma was founded in January 2016 and is headquartered in Tokyo, Japan.
- Ageless — Ageless is a staffing agency that provides human resources-related services primarily to middle-aged and senior citizens.
- Forest — Forest Co., Ltd. operates as an e-commerce aggregator, seeks to identify sustainable, high-quality products and brands that embrace the spirit of Japan and help them grow and enter the global market by using the power of technology.
JMTC Capital (JMTCキャピタル) is the venture capital arm of Japan Material Technologies Corporation. It focuses on investments in R&D-oriented hardware startups in areas such as robotics, drones, personal mobility, wearables, AR/VR, and sensing.
Show more...Investment focus
- Industry: Robotics, Environmental Consulting, Medical Device
- Stage:Series C, Series A
- Geography: Japan, United States
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- F.MED — F.MED is a manufacturing company that designs and develops robotic microsurgical devices for the healthcare industry.
- BioPhenoMA — BioPhenoMA develops an AI-powered platform for detecting ultra-trace proteins that helps accelerate new drug discovery phases.
- Spiral — Spiral is a game changer in providing autonomous drone solutions for indoor environments, most notably during non-GPS situations.
Genesia Ventures is a venture capital firm focused on seed/early stage startups in Japan and Southeast Asia. Since it's inception in Dec 2016, Genesia Ventures has invested in over 90 companies in Japan, Indonesia, Vietnam, Singapore and the US. Genesia Ventures invests in various sectors: SaaS, marketplace, Media, Finance, Insurance,RealEstate, Healthcare, Medical, Travel, Education, Manufacturing, Construction, HR, Agriculture, Sports, Retail, Entertainment, etc.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Seed, Series A
- Geography: Japan, Vietnam, Indonesia
Investor stats
- Total investments: 183
- Lead/follow: no public data
Portfolio highlights
- Mined — Mined is a marketplace that provides online lessons in various subjects for elementary school students. Mind develops and operation of education-related services.
- PartnerProp — PartnerProp is a PRM tool with outstanding potential and a wide variety of capabilities that resolves all partner business difficulties.
- Takumi Giken Kogyo — Takumi Giken Kogyo is a price technology developer to help parts manufacturers quickly identify acceptable product prices. Takumi Giken Kogyo assists in estimate calculation and product function through AI drawing search and repeat project determination function, enabling manufacturers with flexible customization of product functions based oncustomer requirements.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!FueTrek provides a better and faster way to communicate through with speech recognition, speech dialogue, and speech translation.
Show more...Investment focus
- Industry: Mobile, Robotics, Health Care
- Stage:Series A
- Geography: Japan
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Yukai Engineering — YUKAI Engineering - THE ROBOT COMPANY
Chuo Shinkin Venture Capital is a venture fund of Kyoto Chuo Shinkin Bank
Show more...Investment focus
- Industry: Health Care, Sales, Medical
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 8
- Round size: Series A $20M–$128M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Thyas — Thyas Co. Ltd. provides preparations of regenerative immunocell therapy for cancer and infection.
- Regional Fish — Regional Fish provides seed, seedlings, aquaculture methods and fisheries services.
- Space Power Technologies — Space Power Technologies (SPT) was founded in 2019 as Japan's first start-up for “Spatial Transmission Wireless Power Transmission (WPT)”. We will harmonize elemental technologies cultivated through academics with people and society, and solve social issues related to power supply.
Japan Materials Technology commercializes necessary material innovations for society.
Show more...Investment focus
- Industry: Chemical, Software, Recruiting
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- Tryeting — TRYETING provides an AI platform that integrates various types of software. One of the strengths of the company is materials informatics, a field that applies the techniques of informatics, such as AI and big data, to materials. This approach can significantly speed the development of new materials.
- TopoLogic — TopoLogic designs and manufactures heat flow sensors, thermoelectric conversion devices, and topological and novel spintronics materials.
- Sotas — Sotas provides services to chemical trading companies and bridges the gap between raw material producers and consumers.
Will Capital Management is a capital management company that specializes in business development consulting and principal investment.
Show more...Investment focus
- Industry: Aquaculture, Life Science, Biotechnology
- Stage:Seed
- Geography: Japan
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- HOLO BIO — HOLO BIO is a research and technology firm that employs biological breeding techniques to address the food challenges faced by humanity.
HERO Impact Capital is a venture capital firm that co-founds research and development startups.
Show more...Investment focus
- Industry: Solar, Security, Aerospace
- Stage:Series A, Pre-Seed, Series B
- Geography: Japan
Investor stats
- Total investments: 8
- Lead/follow: no public data
Portfolio highlights
- SODEN — SODEN is a technology company that develops and sells electric vehicle chargers and their management software.
- ChillStack — ChillStack provides information on AI, security, and development.
- Cosmobloom Co. — Cosmobloom Co. is a manufacturing company that analyses, designs, and develops space solar power generation systems and solar power sails.
Lifetime Ventures is a VC firm that specializes in pre-seed and seed investments.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Pre-Seed
- Geography: Japan, South Africa, United Kingdom
Investor stats
- Total investments: 39
- Lead/follow: no public data
Portfolio highlights
- Kinish — Kinish is a company leading a revolution in dairy products. To achieve environmentally friendly and delicious dairy products, we are developing a special rice variety that produces milk proteins.
- Kwahuu Ocean — Kwahuu Ocean develops sustainable squid farming systems.
- Spine Chronicle — Spine chronicle is a medical device manufacturing firm that specializes in developing orthopedic medical equipment.
UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Japan, United States, India
Investor stats
- Total investments: 175
- Round size: Seed $3.1M–$54M; Series A $5.2M–$85M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- ImmunoScape — ImmuniScape discovers and develops novel TCR-based therapeutics against solid tumors
- Metcela — Cells hold endless possibilities. Through science, we will unlock these potentials and harness them to improve the lives of patients worldwide.
- Startbahn — Startbahn develops Startrail, a sustainable and scalable blockchain infrastructure that assures the reliability, authenticity, and traceability of artworks.
ReBoost specializes in recruiting and training business.
Show more...Investment focus
- Industry: Content, Medical, Hospital
- Stage:Seed, Pre-Seed
- Geography: Japan
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medii — Medii provides a physician sharing service for hospitals.
- digzyme — Digzyme is a research and development platform for creating, discovering, and evaluating new enzyme-catalyzed reactions by bioinformatics.
- viviane — viviane is running Japan's best video streaming guide, 1Screen.
NCB Venture Capital provides investment to companies.
Show more...Investment focus
- Industry: Recycling, Manufacturing, Management Consulting
- Stage:Series B, Seed, Series C
- Geography: Japan
Investor stats
- Total investments: 17
- Round size: Seed $90k–$115M; Series B $4.7M–$198M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- xxxxnese — xxxxnese is a logistics company that focuses on import, export, domestic sales, influencer marketing, and software development businesses.
- Live Search — Live Search provides the real estate industry with online room availability management, property photography, and floor plan services.
- Turing — Turing develops and manufactures fully autonomous vehicles.
Essential Pharma provided on this site is created for the purpose of providing information on our ethical drugs to medical professionals
Show more...Investment focus
- Industry: Medical, Biotechnology, Genetics
- Stage:Series A
- Geography: Japan
Investor stats
- Total investments: 3
- Round size: Series A $38M–$78M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- HACARUS — We make AI work, where common Big Data aproaches fail. Get explainable results, even from small data amounts. Available on the cloud or as embedded devices.
- HekaBio — HekaBio connects world-leading healthcare innovations to unmet medical needs in the Asia Pacific, with broad category development expertise in pharma, medical device, in-vitro diagnostics, digital health, and cell & gene therapies.
- Jiksak Bioengineering — Jiksak Bioengineering is a biotechnology company. Jiksak Bioengineering provide an efficient screening service using a three-dimensional cell tissue "Nerve Organoid". We will mainly develop screening technologies specifically for neurodegenerative diseases and search for drugs that are effective for amyotrophic lateral sclerosis (ALS).
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Mitsui Mining & Smelting Company, Ltd. mainly produces non-ferrous metal such as lead and copper alloys.
Show more...Investment focus
- Industry: Medical, Water, AgTech
- Stage:Series A, Series B
- Geography: Japan, United States
Investor stats
- Total investments: 5
- Round size: Series A $8M–$50M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Alpha Fusion — Alpha Fusion Inc. is a clinical-stage startup committed to transforming cancer treatment through the design and development of powerful and precise radiopharmaceuticals.
- Chitose Group — CHITOSE GROUP is a family of biotechnology companies operating mainly in Southeast Asia and Japan with an aim of leaving mankind with an environment where they can live in abundance for over a thousand years. CHITOSE GROUP is creating new values in the fields of agriculture, medical, food, energy, chemistry and others through “Technologicaldevelopment capabilities in the biotechnology field by constantly promoting economic rationality” and “Business development capabilities for drawing a path towards commercialization by understanding the essence and limitations of biotechnology”.
- WaHa — WaHa's innovative atmospheric water generator creates sustainable water solutions from air. Experience pure water generation with the WaHa Vaporator system.
Fast Track Initiative is a venture capital firm with an exclusive focus on life sciences and healthcare services.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 77
- Round size: Seed $1.2M–$117M; Series A $1.1M–$142M; Series B $7.7M–$184M
- Lead/follow: 26% lead, 74% follow
- Last fund: May invest from a new fund soon — raised $1.1B in 2021
Portfolio highlights
- Global Vascular —
- Sonire Therapeutics — Sonire Therapeutics provides High-Intensity Focused Ultrasound treatment for cancer.
- Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
IT-Farm is a venture capital firm which specializes in seed, start-up, and early stage companies. It primarily invests in mobile, big-data, connected car, IoT, OTT service, Helth care, Bio Tech and other IT industries. The firm actively invests in SF bay area and Japan, as well as other geometries including Asia and Europe. We support portfoliocompanies, especially on the partnership with Japanese enterprises.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Series A
- Geography: United States, Japan, Germany
Investor stats
- Total investments: 115
- Lead/follow: no public data
Portfolio highlights
- Ubitus — As cloud gaming enablers, Ubitus' GPU virtualization, Streaming technology and hybrid cloud deployment can serve different kinds of solutions for Telco, Game companies to quick enter cloud gaming market. Moreover, Ubitus provide Global distribution and New Media content solution for new media studio and fashion brand to help them distribute rich media contents worldwide.
- Drivezy — Own the Experience, not the Car
- Address — ADDress is a provider of co-living spaces in both urban and rural areas, enabling people to live in a range of luxurious residences at fixed prices.
FFG Venture Business Partners is a large-scale enterprise that offers in traditional regional bank venture capital.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Series A, Seed
- Geography: Japan, United States
Investor stats
- Total investments: 67
- Lead/follow: no public data
Portfolio highlights
- FELIQS — FELIQS is a preclinical-stage start-up company established based on the robust science from molecular pathobiology, department of pharmaceutical science, Kyushu university.
- ATOMica — ATOMica is a co-working space and business management company for conference rooms, event venues, circles, and schools. The company uses coworking spaces as HUBs to provide services that maximize individuals' power. It can be used for a variety of purposes, including coworking space, shared office space, meetings, events, and web seminars. Itis also possible to use it only once. They plan and run local communities that bring together a diverse range of people, including students, workers, businesses, universities, and governments.
- OPTEMO — OPTEMO develops and supplies sales technology that allows businesses and customers to connect through a website.
Chushin Venture Capital is a venture capital fund established by Kyoto Chuo Shinkin Bank.
Show more...Investment focus
- Industry: Retail, Travel, Home Decor
- Stage:Series A, Series B
- Geography: Japan
Investor stats
- Total investments: 8
- Lead/follow: no public data
Portfolio highlights
- Cizucu — Cizucu is a stock photo community that helps creators and brands to create photos.
- HOLO BIO — HOLO BIO is a research and technology firm that employs biological breeding techniques to address the food challenges faced by humanity.
- RadioNano Therapeutics — RadioNano Therapeutics is developing innovative drugs for Boron Neutron Capture Therapy (BNCT), a type of radiation therapy that utilizes the nuclear reaction between thermal neutrons and boron-10 (¹⁰B) to destroy cancer cells by releasing alpha particles and lithium nuclei.
Sosei CVC is support the creation and growth of life science companies.
Show more...Investment focus
- Industry: Biotechnology, Medical, Pharmaceutical
- Stage:Series A, Series B
- Geography: Japan
Investor stats
- Total investments: 7
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Junten Bio — JUNTEN BIO is a company is to develop new technologies in the field of regenerative medicine.
- Chromocenter — Chromocenter is a next generation biopharmaceuticals Manufacturing company. It uses technologies such as artificial chromosome vectors, mainly for drug discovery such as medical pharmaceuticals
- Noile-Immune Biotech — Neurymune Biotech Co., Ltd. is a national cancer research center specializing in the development of cancer immunotherapies based on CAR-T cell therapy and a venture company from Yamaguchi University. They aim to be a leading company responsible for the next generation in the field of cancer immunotherapy.
QB Capital is make equity investments in venture companies.
Show more...Investment focus
- Industry: Manufacturing, Medical, Biotechnology
- Stage:Seed, Series A
- Geography: Japan, Singapore, United States
Investor stats
- Total investments: 51
- Round size: Seed $641k–$43M; Series A $5.2M–$400M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $429M in 2015
Portfolio highlights
- Mechano Cross — Mechano Cross is a mechanical company that offers mechanochemical organic synthesis technology for solution reactions.
- Surv Biopharma — Surv Biopharma develops a drug discovery platform that facilitates research and development of veterinary drugs and pharmaceutical products.
- Zip Infrastructure — Inquiry : https://docs.google.com/forms/d/e/1FAIpQLSfDmxd1TpPP331TY4VoRsvn0yWX3Ca5Jd-bfBiuPwvpD2SKtA/viewform
Innovation Engine has been is promoting investment to create and grow promising business areas created from technology.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series C
- Geography: Japan, Spain
Investor stats
- Total investments: 38
- Round size: Series A $663k–$71M; Series C $44M–$85M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $191M in 2019
Portfolio highlights
- Asilla — Asilla develops and provides AI specialized in image and video analysis. Its services, the Vehicle recognition AI, recognizes the manufacturer and model from the image of the vehicle. It also has a censorship service that detects inappropriate images that can not be released, including copyrights and obscene expressionsAsilla was founded in 2015and is based in Tokyo, Japan.
- bestat — bestat is a developer of platforms for 3D data creation, management, and utilization using AI and offers digital twins services.
- Drone Show Japan — Drone Show Japan company specializes in drone shows for events, aerial photography, and workshops.
Kaga Electronics is a Japan based company engages in the sales of electronic components, electronic devices and other. It operates through following segments: Electronic Components, Information Equipment, Software and Other. The firm generates majority revenue from the Electronic Components.
Show more...Investment focus
- Industry: Education, Artificial Intelligence, Medical
- Stage:Series A, Seed
- Geography: Japan, Taiwan
Investor stats
- Total investments: 15
- Round size: Series A $38M–$105M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- DriveX — DriveX is a consulting firm that helps in creating new businesses using AI solutionst.
- Linkage — Linkage is a Online health support business and Online specific health guidance.
- CI Partners — CI Partners mission is to "eliminate the word 'disability' from this country," and with the message "Everyone is a star."
Fuyo General Lease focuses in the leasing and installment sales trading of equipment and fixtures, and financial transaction. The company provides leasing services of information-related equipment, office equipment, and industrial equipment, installment sales of commercial facilities, production facilities, and hospital facilities. It also providessecurities management services and anonymous association composition.Fuyo General Lease was founded on 1969 and is headquartered in Tokyo, Japan.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Sales
- Stage:Series A, Corporate Round
- Geography: Japan
Investor stats
- Total investments: 17
- Round size: Series A $21M–$241M; Corporate Round $4.3M–$28M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Quants — Quants uses AI qualitative credit technology to provide financing services. The company creates Type 21, an artificial intelligence with a credit screening circuit that runs automatically. HIF aims to provide appropriate funds to corporations and individuals.
- avatarin — avatarin develops next-generation mobility and human augmentation platforms.
- 3D Printing Corporation — 3D Printing Corporation provides 3D printing technology solutions.
Life Science VC funding in Japan at a glance
Stats across 86 deals from 154 investors.
Access all 154 VC funds in Japan Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science VC Funds in Japan investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 154 VC funds investing in Japan Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!